Astellas' filing of lower urinary tract combo may sustain tamsulosin in EU
This article was originally published in Scrip
Executive Summary
A new approval filing for a combination urology product in the EU should enable the easier treatment of a broad range of bladder and prostate problems in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia with storage symptoms.